Search for:
Search Button
Investors
Press Releases
Events and Presentations
Scientific & Medical Presentations
SEC Filings
Corporate Governance
Stock Information
Investor FAQs
Email Alerts
Patients
About
Board of Directors
Global Scientific Advisory Board
Management Team
Retinal Disease
Technology
Pipeline
Clinical Trials
OTX-TKI
OTX – TIC
Products
Careers
Benefits
Open Positions
Contact Us
Search for:
Search Button
Investors
Press Releases
Events and Presentations
Scientific & Medical Presentations
SEC Filings
Corporate Governance
Stock Information
Investor FAQs
Email Alerts
Patients
About
Board of Directors
Global Scientific Advisory Board
Management Team
Retinal Disease
Technology
Pipeline
Clinical Trials
OTX-TKI
OTX – TIC
Products
Careers
Benefits
Open Positions
Contact Us
Investors
Press Releases
Events and Presentations
Scientific & Medical Presentations
SEC Filings
Corporate Governance
Stock Information
Investor FAQs
Email Alerts
Patients
Careers
Benefits
Open Positions
Contact Us
Investors
Press Releases
Events and Presentations
Scientific & Medical Presentations
SEC Filings
Corporate Governance
Stock Information
Investor FAQs
Email Alerts
Patients
Careers
Benefits
Open Positions
Contact Us
About
Management Team
Board of Directors
Global Scientific Advisory Board
Retinal Disease
Technology
Pipeline
Clinical Trials
OTX-TKI
OTX-TIC
Products
About
Management Team
Board of Directors
Global Scientific Advisory Board
Retinal Disease
Technology
Pipeline
Clinical Trials
OTX-TKI
OTX-TIC
Products
Search
SriniVas Sadda, MD
Professor of Ophthalmology, Doheny Eye Institute, UCLA
